Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.3 EUR | +0.81% | -1.88% | -26.07% |
Apr. 04 | DERMAPHARM : Berenberg keeps its Buy rating | ZD |
Mar. 28 | Dermapharm Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 1.17B 1.25B | Sales 2025 * | 1.22B 1.3B | Capitalization | 1.69B 1.8B |
---|---|---|---|---|---|
Net income 2024 * | 112M 120M | Net income 2025 * | 130M 139M | EV / Sales 2024 * | 2.14 x |
Net Debt 2024 * | 812M 868M | Net Debt 2025 * | 699M 747M | EV / Sales 2025 * | 1.95 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
13
x | Employees | 3,497 |
Yield 2024 * |
3.36% | Yield 2025 * |
3.84% | Free-Float | 32.26% |
1 day | +0.81% | ||
1 week | -1.57% | ||
Current month | -4.11% | ||
1 month | -6.06% | ||
3 months | -18.02% | ||
6 months | -17.54% | ||
Current year | -26.07% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 17-07-31 | |
Director of Finance/CFO | - | 22-10-31 | |
Britta Hamberger
IRC | Investor Relations Contact | - | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 17-12-31 | |
Wilhelm Beier
CHM | Chairman | 68 | 17-07-31 |
Erwin Kern
BRD | Director/Board Member | 63 | 17-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.01% | 125 M€ | -.--% | ||
0.73% | 17 M€ | -.--% | - | |
0.16% | 79 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 31.3 | +0.81% | 38,113 |
24-04-25 | 31.05 | -1.43% | 22,157 |
24-04-24 | 31.5 | -3.08% | 34,510 |
24-04-23 | 32.5 | -0.61% | 22,522 |
24-04-22 | 32.7 | +2.51% | 32,788 |
Delayed Quote Xetra, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.07% | 1.79B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- DMP Stock